ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,071.63
0.02%
Dow Jones
38,460.92
-0.11%
US Dollar vs MXN
17.08341
-0.01%
Brent Oil
87.295
0.09%
Bitcoin
64,198.60
-0.13%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. AMEX
  6. IGC Pharma Inc (IGC)

  7. IGC Pharma Inc (IGC) Noticias

IGC IGC Pharma Inc

0.428
-0.0286 (-6.26%)
24 Abr 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
IGC Pharma Inc IGC AMEX Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.0286 -6.26% 0.428 18:55:07
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.4626 0.413 0.468818 0.439 0.4566
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
16/4/202406:00BWIGC-AD1’s Interim Phase 2 Data Show a Reduction in..
09/4/202408:00BWIGC Pharma Adds Advisor in Artificial Intelligence
26/3/202414:00BWIGC Pharma Announces $3 Million Unregistered Private..
20/3/202410:00BWIGC Pharma Announces Positive Interim Results for IGC-AD1 in..
20/3/202406:00BWIGC PHARMA Announces its Participation at the Benzinga..
12/3/202414:00BWIGC Pharma (IGC): Healthcare Leader Terry Lierman Joins..
28/2/202412:00BWPromising Results: TGR-63 Enhances Memory in Alzheimer's..
23/2/202411:01BWIGC Pharma Announces Equity Analyst Coverage by Ascendiant..
16/2/202418:05BWIGC Pharma Reports Third Quarter Fiscal 2024 Results
14/2/202415:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/2/202408:20BWIGC Pharma Announces TGR-63 Reduces Agitation in Alzheimer's..
31/1/202415:04EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
23/1/202408:20BWIGC Pharma Breakthrough: Preclinical Trial Data Shows TGR-63..
17/1/202408:20BWIGC Pharma Activates ClinCloud, One of 12 Sites in Ongoing..
08/1/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
29/12/202315:54EDGAR2Form S-3 - Registration statement under Securities Act of..
19/12/202308:20BWPatent Granted to IGC Pharma for Groundbreaking Drug..
13/12/202308:30BWIGC Pharma Announces Participation in Biotech Showcase and..
06/12/202307:30BWIGC Pharma Announces Collaboration to Integrate AI into..
21/11/202307:30BWIGC Pharma Announces Master Agreement with Leading South..
13/11/202307:00BWIGC Pharma Reports Second Quarter Fiscal 2024 Results
09/11/202316:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
27/10/202316:21EDGAR2Form 8-K - Current report
27/10/202315:38EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
19/10/202314:30BWIGC Pharma Granted European Patent for Groundbreaking..
29/9/202316:23EDGAR2Form S-3 - Registration statement under Securities Act of..
21/8/202313:30BWIGC Announces Results of its 2023 Annual Stockholders..
21/8/202311:44EDGAR2Form 8-K - Current report
14/8/202307:30BWIGC Pharma Reports First Quarter Results; Company Continues..
10/8/202315:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/8/202307:30BWIGC Pharma Expands Phase 2 Trial of IGC-AD1 to Include the..
26/7/202316:26EDGAR2Form DEF 14A - Other definitive proxy statements
18/7/202304:22BWIGC Pharma, Inc. Presenting 6 Posters on the Positive Impact..
12/7/202307:44BWIGC Reports Financial Results for Fiscal Year Ended March..
07/7/202315:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
07/7/202310:41EDGAR2Form 8-K - Current report
07/7/202308:15BWIGC Pharma Secures $12 Million Line of Credit from O-Bank..
06/7/202306:46BWIGC Pharma Announces a $3 Million Private Placement of its..
30/6/202315:03EDGAR2Form NT 10-K - Notification of inability to timely file Form..
28/6/202320:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/6/202312:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202308:20BWIGC Pharma Receives Notice of Allowance for Patent on..
05/6/202307:30BWIGC Pharma’s Advisor and Inventor of Drug Candidate TGR-63..

Su Consulta Reciente

AMEX
IGC
IGC Pharma
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados